Article Sidebar
Published:
Feb 12, 2014DOI:
10.4314/tjpr.v13i1.8Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Salvianolic Acid B Ameliorates Motor Dysfuntion in Spinal Cord Injury Rats
Abstract
Purpose: To evaluate the effect of salvianolic acid B (Sal B) treatment on the motor function of spinal cord injury (SCI) rat.
Methods: SCI rats were modelled by contusion, and then received 10 mg/kg Sal B, or methylprednisolone, or phosphate-buffered saline (PBS) intraperitoneally daily for 4 weeks, two hours after the trauma occurred. During the treatment, footprint analysis (FA), inclined plane test (IPT), Basso-Beattie-Bresnahan (BBB) rating and Schnell Swim Test (SST) were used for estimating the recovery of motor function. At the same time, tissue edema was measured by wet-dry weighting, and the secretion of cytokines were indirectly quantitated by real time polymerase chain reaction (qPCR).
Results: Primarily, Sal B group rats scored higher by FA, IPT and BBB rating. Further statistical analysis of comprehensive SST data from Student-t test indicates that Sal B can significantly ameliorate motor dysfunction after a 4-week treatment (p < 0.05) as well. Furthermore, Sal B decreased water content of the edema by 16.5 % during the first week, and sharply downregulated the transcription of interleukin 6 (IL-6) and tumor necrosis factor (TNF-α) 28- and 16-fold, respectively.
Conclusion: The beneficial effect of motor function recovery was observed in SCI rats following intraperitoneal administration of Sal B.
Keywords: Salvianolic acid B, Spinal cord injury, Motor dysfunction, Cytokines
